DEA Issues Alert on Rise of Fentanyl Mixed with Xylazine
- Mar 31
Bipartisan Senate Group Introduces Legislation to Crack Down on Xylazine


- Mar 31
FDA Approves Over-the-Counter Narcan
- Mar 31
Study Shows High Prevalence of Buprenorphine 'Spiking' in Urine Screenings for OUD Patients
- Mar 31
SAMHSA Warns of Growing Threat from Xylazine
- Mar 31
Naloxone Expansion Not Associated with Increases in Adolescent Injection Drug Use
- Mar 24
House Members Form Bipartisan Fentanyl Prevention Caucus


- Mar 24
New NIDA Study Reveals Shared Genetic Markers Underlying Substance Use Disorders
- Mar 24
Study Suggests High-Dose Buprenorphine is Useful Among Patients Using Fentanyl and Other Opioids
- Mar 17
Apply for Three NHSC Loan Repayment Programs in Just One Application
- Mar 17
LAPPA Releases Model Act on Substance Use During Pregnancy and Family Care Plans
- Mar 17
SAMHSA Seeking $10.8 Billion in FY 2024 to Bolster Mental Health and Substance Use Services
- Mar 3
Senate HELP Committee Requests Input to Address Health Workforce Shortage


- Mar 3
Addiction Treatment May Be Coming to a Pharmacy Near You


- Mar 3
U.S. Deaths Involving Meth Are Skyrocketing, Fentanyl a Big Factor
- Mar 3
FDA Acts to Restrict Illicit Import of Xylazine, Animal Tranquilizer Linked to Overdose Deaths


- Mar 3
Trauma Causes High Levels of Intergenerational Substance Use Among Black Women


- Feb 24
U.S. Teen Girls Experiencing Increased Sadness and Violence
- Feb 17
Bill Introduced to Establish Felony Murder Charges for Fentanyl Dealers


- Feb 17
More Than 1 in 9 U.S. Adults With Co-Occurring Mental Illness and Substance Use Disorders Are Arrest